Canada markets closed

Cytosorbents Corporation (CTSO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.8190+0.0100 (+1.24%)
At close: 04:00PM EDT
0.8140 -0.00 (-0.61%)
After hours: 07:42PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 43.93M
Enterprise Value 48.12M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.16
Price/Book (mrq)1.89
Enterprise Value/Revenue 1.55
Enterprise Value/EBITDA -1.65

Trading Information

Stock Price History

Beta (5Y Monthly) 0.59
52-Week Change 3-66.98%
S&P500 52-Week Change 321.08%
52 Week High 34.2900
52 Week Low 30.7820
50-Day Moving Average 30.9334
200-Day Moving Average 31.6455

Share Statistics

Avg Vol (3 month) 3100.94k
Avg Vol (10 day) 392.15k
Shares Outstanding 554.31M
Implied Shares Outstanding 654.31M
Float 846.68M
% Held by Insiders 19.38%
% Held by Institutions 138.01%
Shares Short (Apr 15, 2024) 41.55M
Short Ratio (Apr 15, 2024) 413.88
Short % of Float (Apr 15, 2024) 42.94%
Short % of Shares Outstanding (Apr 15, 2024) 42.86%
Shares Short (prior month Mar 15, 2024) 41.67M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Dec 05, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -78.43%
Operating Margin (ttm)-102.45%

Management Effectiveness

Return on Assets (ttm)-32.48%
Return on Equity (ttm)-97.21%

Income Statement

Revenue (ttm)36.35M
Revenue Per Share (ttm)0.81
Quarterly Revenue Growth (yoy)-7.70%
Gross Profit (ttm)N/A
EBITDA -28.81M
Net Income Avi to Common (ttm)-28.51M
Diluted EPS (ttm)-0.6400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.13M
Total Cash Per Share (mrq)0.26
Total Debt (mrq)18.31M
Total Debt/Equity (mrq)78.68%
Current Ratio (mrq)1.77
Book Value Per Share (mrq)0.43

Cash Flow Statement

Operating Cash Flow (ttm)-21.66M
Levered Free Cash Flow (ttm)-12.12M